Home | Breaking Out | AI powered stock trade ideas | Bullish Engulfing | Market Signals | New Green Signal Stocks | Recent Red Arrow Top Signals | Recent Green Arrow Bottom Signals | Near Term Bottom Signals | Green Stocks with Most Upside to Analyst Target Price | New Long Term Green AI Signals | Big Tech Stocks | ETF Sector SPDRs | Solar Stocks | Chip Stocks | Airline Stocks | Social Media Stocks | Oil Stocks| Discount Store Stocks | Entertainment Stocks | EV Stocks | Restaurant Stocks | Heavy Equipment Stocks | Aerospace Stocks | Home Builders | Bank Stock Signals | Cruise Ship Stock Signals | Mining Stocks | Free AI Portfolio Analyzer | How to Read and Trade AI Powered Stock Charts| Stock Charts AI top 50 Stocks

Recently Featured Stock Charts
86% AI Stock Prediction Accuracy
Enter Stock Symbol to View AI powered Stock Chart


All Chart Prices Delayed at least 15 minutes

Before accessing this site, you agree that you have read and agree to the disclaimers at the bottom of this page.

Stock Charts AI Power Rank: 4.3
Power Rank trending -> DOWN

Last Price: 39.98 - Change: -2.86 - Change %: -6.676
06/24/2024 16:00:00 EST

Tandem Diabetes Care Inc (TNDM)

Industry: Medical Devices

Price Support Resistance

In the past 20 trading days, TNDM has been trading in a range between $53.43 and $42.83 (gray range band). Red lines on the chart represent key resistance levels and Green lines represent key support levels. As the price moves above the lines you will notice they turn green and red if price moves below a line.

The AI powered stock chart is in a Red zone currently. We would avoid this stock.

Upside / Downside Potential

Tandem Diabetes Care Inc $TNDM entered a Red zone 5 days ago on the AI powered stock chart. Wall Street analysts have an AVG target price $39.33, a potential down side of -1.63% from the recent price of 39.98. The stock is trading 34.29% (potential upside) below its 52 week high of $53.69 and 189.29 % (potential downside) above its 52 week low of $13.82 - based on the recent price.

Company Summary

Tandem Diabetes Care, Inc, a medical device company, designs, develops, and commercializes technology solutions for people living with diabetes in the United States and internationally. The company's flagship product is the t:slim X2 insulin delivery system, a pump platform for managing insulin delivery and display continuous glucose monitoring sensor information directly on the pump home screen; and Tandem Mobi insulin pump, an automated insulin delivery system.

TNDM Website


Tandem Mobi Improves Quality of Life for People Living With Type 1 Diabetes in New Data Shared at American Diabetes Association Scientific Sessions
SAN DIEGO--(BUSINESS WIRE)---- $TNDM #TandemMobi--Tandem Diabetes Care today presented positive real-world data from a Tandem Mobi user satisfaction survey at the 2024 ADA Scientific Sessions.
Source: Business Wire
Sat, 22 Jun 2024 11:00:00 -0400
Sentiment: Neutral
Tandem Diabetes Care Appoints Jean-Claude Kyrillos as Chief Operating Officer
SAN DIEGO--(BUSINESS WIRE)-- #TandemDiabetes--Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today announced the appointment of Jean-Claude “JC” Kyrillos as Executive Vice President and Chief Operating Officer, effective June 21, 2024. Mr. Kyrillos comes to Tandem with more than 20 years of global executive leadership experience in medical device, digital health, and healthcare management. “JC brings deep experience in healthcare and a great balance of tech.
Source: Business Wire
Thu, 20 Jun 2024 09:00:00 -0400
Sentiment: Neutral
The 3 Best Diabetes Stocks to Buy in June 2024
Since last October, there has been a marked reduction in fears about the sales of diabetes drugs dropping as a result weight-loss drugs. That's because Dexcom (NASDAQ: DXCM ) delivered stronger-than-expected third-quarter results in October.
Source: InvestorPlace
Wed, 19 Jun 2024 06:02:00 -0400
Sentiment: Positive
Tandem Diabetes Care to Present New Early User Insights on the Tandem Mobi System at the American Diabetes Association's 84th Scientific Sessions
SAN DIEGO--(BUSINESS WIRE)-- #TandemDiabetes--Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today announced its schedule of presentations for the American Diabetes Association's (ADA) 84th Scientific Sessions taking place in Orlando, Florida from June 21-24. Product Theater The Company will host a Product Theater on Saturday, June 22 from 10:15 am - 11:00 am EDT at Product Theater #1. Meet Tandem Mobi: Tiny pump, big control. The future of Automated Insuli.
Source: Business Wire
Tue, 18 Jun 2024 09:00:00 -0400
Sentiment: Neutral
Here's Why You Should Hold on to Tandem Diabetes (TNDM) Now
Innovations and a robust diabetes market outlook raise investors' optimism for Tandem Diabetes (TNDM).
Source: Zacks Investment Research
Wed, 05 Jun 2024 09:16:15 -0400
Sentiment: Positive
Instituions Institution %: 117.152
Last QTR Institution change: 4463351

Insiders %: 0.755
Insiders Purchases last QTR: 14135
Insiders Sales last QTR: 5000
Insiders Net last QTR: 9135

Analyst Ratings
Target Price: 39.33
Overall Rating: 4.0588
Strong Buys (5): 9
Buys (4): 2
Holds (3): 4
Sells (2): 2
Strong Sells (1): 0

52 Week Hi: 53.69
52 Week Low: 13.82
Beta: 1.273
50 Day MA: 43.2292
200 Day MA: 28.9185

Earnings / Revenue Trends
Qtr Earnings Growth YOY: -0.37
Qtr Revenue Growth YOY: 0.132
Forward PE: 1111.1111
Trailing PE: 0

Benefits of StockChartsAI.com System:

  • Get a Daily List of Stocks Starting New Trends
  • Upload Your Stocks to Quickly See and Track Signals
  • Easy to Understand AI Stock Signals
  • Analysis of Historical Signal Trend Analysis for each stock
  • Search/View AI Stock Signals of Russel 1000 Stocks
  • Easy to Understand AI Stock Signals
  • And MUCH MUCH more!


Stock Analyzed Each Night


Easily Upload Track Your Stocks


See Lists of Stocks Starting New Trends

The information contained on this website is solely for educational purposes, and does not constitute investment advice. The risk of trading in securities markets can be substantial. By accessing this site, you agree we are not liable, whether in contract, tort (including negligence) or otherwise, in respect of any damage, expense or other loss you may suffer arising out of such information or any reliance you may place upon such information from this site. Stocks, Futures and options trading has large potential rewards, but also large potential risk. You must be aware of the risks and be willing to accept them in order to invest in the stock, futures and options markets. Don't trade with money you can't afford to lose. This website is neither a solicitation nor an offer to Buy/Sell futures or options. No representation is being made that any account will or is likely to achieve profits or losses similar to those discussed on this website. The past performance of any trading system or methodology is not necessarily indicative of future results. Individual results may vary, and testimonials are not claimed to represent typical results. All testimonials are by real people, and may not reflect the typical purchaser’s experience, and are not intended to represent or guarantee that anyone will achieve the same or similar results. HYPOTHETICAL OR SIMULATED PERFORMANCE RESULTS HAVE CERTAIN LIMITATIONS. UNLIKE AN ACTUAL PERFORMANCE RECORD, SIMULATED RESULTS DO NOT REPRESENT ACTUAL TRADING. ALSO, SINCE THE TRADES HAVE NOT BEEN EXECUTED, THE RESULTS MAY HAVE UNDER-OR-OVER COMPENSATED FOR THE IMPACT, IF ANY, OF CERTAIN MARKET FACTORS, SUCH AS LACK OF LIQUIDITY, SIMULATED TRADING PROGRAMS IN GENERAL ARE ALSO SUBJECT TO THE FACT THAT THEY ARE DESIGNED WITH THE BENEFIT OF HINDSIGHT. NO REPRESENTATION IS BEING MADE THAT ANY ACCOUNT WILL OR IS LIKELY TO ACHIEVE PROFIT OR LOSSES SIMILAR TO THOSE SHOWN.